Clinical standards for drug-susceptible TB: putting patients first
No Abstract
Document Type: Editorial
Affiliations: 1: Department of 1Internal Medicine, Division of Infectious Diseases, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands, Department of Pulmonary Diseases & Tuberculosis, Division of Infectious Diseases, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands 2: Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam University Medical Centers, Amsterdam Infection and Immunity, Amsterdam Public Health, University of Amsterdam, Amsterdam, the Netherlands, Institute of Tropical Medicine, University of Tübingen, Tübingen, Germany, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa, Centre de Recherches Médicales en Lambaréné, Lambaréné, Gabon, Masanga Medical Research Unit, Masanga, Sierra Leone
Publication date: July 1, 2022
The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.
The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- International Journal of Tuberculosis and Lung Disease
- Public Health Action
- Ingenta Connect is not responsible for the content or availability of external websites
Receive new issue alert- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content